BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warfel JM, Merkel TJ. The baboon model of pertussis: effective use and lessons for pertussis vaccines. Expert Review of Vaccines 2014;13:1241-52. [DOI: 10.1586/14760584.2014.946016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Bouchez V, Guiso N, Carbonetti N. Bordetella pertussis , B. parapertussis , vaccines and cycles of whooping cough. Pathogens and Disease 2015;73:ftv055. [DOI: 10.1093/femspd/ftv055] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
2 Kapil P, Merkel TJ. Pertussis vaccines and protective immunity. Curr Opin Immunol 2019;59:72-8. [PMID: 31078081 DOI: 10.1016/j.coi.2019.03.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
3 Burdin N, Handy LK, Plotkin SA. What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines. Cold Spring Harb Perspect Biol 2017;9:a029454. [PMID: 28289064 DOI: 10.1101/cshperspect.a029454] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 8.2] [Reference Citation Analysis]
4 Sartoretti J, Eberhardt CS. The Potential Role of Nonhuman Primate Models to Better Comprehend Early Life Immunity and Maternal Antibody Transfer. Vaccines (Basel) 2021;9:306. [PMID: 33804886 DOI: 10.3390/vaccines9040306] [Reference Citation Analysis]
5 Saso A, Kampmann B, Roetynck S. Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines. Vaccines (Basel) 2021;9:877. [PMID: 34452002 DOI: 10.3390/vaccines9080877] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Scanlon K, Skerry C, Carbonetti N. Association of Pertussis Toxin with Severe Pertussis Disease. Toxins (Basel) 2019;11:E373. [PMID: 31252532 DOI: 10.3390/toxins11070373] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
7 Citron MP, McAnulty J, Callahan C, Knapp W, Fontenot J, Morales P, Flynn JA, Douglas CM, Espeseth AS. Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs. Pathogens 2021;10:1441. [PMID: 34832599 DOI: 10.3390/pathogens10111441] [Reference Citation Analysis]
8 Locht C, Carbonetti NH, Cherry JD, Damron FH, Edwards KM, Fernandez R, Harvill ET, Hozbor D, Mills KHG, Rodriguez ME, Mascart F. Highlights of the 12th International Bordetella Symposium. Clin Infect Dis 2020;71:2521-6. [PMID: 32463883 DOI: 10.1093/cid/ciaa651] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pinto MV, Merkel TJ. Pertussis disease and transmission and host responses: insights from the baboon model of pertussis. J Infect 2017;74 Suppl 1:S114-9. [PMID: 28646950 DOI: 10.1016/S0163-4453(17)30201-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
10 Plotkin SA, Gilbert P. Correlates of Protection. Plotkin's Vaccines. Elsevier; 2018. pp. 35-40.e4. [DOI: 10.1016/b978-0-323-35761-6.00003-1] [Cited by in Crossref: 9] [Article Influence: 2.3] [Reference Citation Analysis]
11 Rodrigues CMC, Pinto MV, Sadarangani M, Plotkin SA. Whither vaccines? J Infect 2017;74 Suppl 1:S2-9. [PMID: 28646957 DOI: 10.1016/S0163-4453(17)30184-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
12 Jennings-Gee J, Quataert S, Ganguly T, D'Agostino R Jr, Deora R, Dubey P. The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs. Infect Immun 2018;86:e00935-17. [PMID: 29531137 DOI: 10.1128/IAI.00935-17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
13 Poolman JT. Foreword. Pertussis vaccines. Expert Rev Vaccines 2014;13:1067-9. [PMID: 25115214 DOI: 10.1586/14760584.2014.946910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Warfel JM, Edwards KM. Pertussis vaccines and the challenge of inducing durable immunity. Current Opinion in Immunology 2015;35:48-54. [DOI: 10.1016/j.coi.2015.05.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 8.9] [Reference Citation Analysis]
15 Lönnqvist E, Barkoff A, Mertsola J, He Q. Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006–2017. Journal of Global Antimicrobial Resistance 2018;14:12-6. [DOI: 10.1016/j.jgar.2018.02.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hiramatsu Y, Suzuki K, Nishida T, Onoda N, Satoh T, Akira S, Ikawa M, Ikeda H, Kamei J, Derouiche S, Tominaga M, Horiguchi Y. The Mechanism of Pertussis Cough Revealed by the Mouse-Coughing Model. mBio 2022;:e0319721. [PMID: 35357202 DOI: 10.1128/mbio.03197-21] [Reference Citation Analysis]
17 Caution K, Yount K, Deora R, Dubey P. Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice. J Vis Exp 2019. [PMID: 30855568 DOI: 10.3791/58930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Rubin FA, Koso-Thomas M, Isaacs MB, Piper J, Read J, Nesin M. Maternal immunization efforts of the National Institutes of Health. Vaccine 2015;33:6380-7. [PMID: 26458798 DOI: 10.1016/j.vaccine.2015.08.097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
19 Carbonetti NH. Contribution of pertussis toxin to the pathogenesis of pertussis disease. Pathog Dis 2015;73:ftv073. [PMID: 26394801 DOI: 10.1093/femspd/ftv073] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
20 Clemmons EA, Chavez D, Condel L, Dutton JW 3rd, Price S, Lanford R. Comparison of oral, nebulized and combination antibiotic treatment of Bordetella bronchiseptica in baboons (Papio spp.). J Vet Pharmacol Ther 2021. [PMID: 33963570 DOI: 10.1111/jvp.12975] [Reference Citation Analysis]
21 Kara EO, Campbell H, Ribeiro S, Fry NK, Litt D, Eletu S, Amirthalingam G. Survey of Household Contacts of Infants With Laboratory-confirmed Pertussis Infection During a National Pertussis Outbreak in England and Wales. Pediatric Infectious Disease Journal 2017;36:140-5. [DOI: 10.1097/inf.0000000000001378] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
22 Plotkin SA. Updates on immunologic correlates of vaccine-induced protection. Vaccine 2020;38:2250-7. [PMID: 31767462 DOI: 10.1016/j.vaccine.2019.10.046] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 12.7] [Reference Citation Analysis]
23 Scanlon K, Skerry C, Carbonetti N. Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis. Adv Exp Med Biol 2019;1183:35-51. [PMID: 31376138 DOI: 10.1007/5584_2019_403] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
24 Mask E, Hodara VL, Callery JE, Parodi LM, Obregon-perko V, Yagi S, Glenn J, Frost P, Clemmons E, Patterson JL, Cox LA, Giavedoni LD. Molecular Approaches for the Validation of the Baboon as a Nonhuman Primate Model for the Study of Zika Virus Infection. Front Cell Infect Microbiol 2022;12:880860. [DOI: 10.3389/fcimb.2022.880860] [Reference Citation Analysis]
25 Lambert EE, Buisman AM, van Els CACM. Superior B. pertussis Specific CD4+ T-Cell Immunity Imprinted by Natural Infection. Adv Exp Med Biol 2019;1183:81-98. [PMID: 31321753 DOI: 10.1007/5584_2019_405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
26 Ben Fraj I, Smaoui H, Zghal M, Sassi O, Guiso N, Kechrid A. Seroprevalence of pertussis among healthcare workers: A cross-sectional study from Tunisia. Vaccine 2019;37:109-12. [PMID: 30459070 DOI: 10.1016/j.vaccine.2018.11.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
27 Warfel JM, Zimmerman LI, Merkel TJ. Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis. Clin Vaccine Immunol 2016;23:47-54. [PMID: 26561389 DOI: 10.1128/CVI.00449-15] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
28 Choi YH, Campbell H, Amirthalingam G, van Hoek AJ, Miller E. Investigating the pertussis resurgence in England and Wales, and options for future control. BMC Med 2016;14:121. [PMID: 27580649 DOI: 10.1186/s12916-016-0665-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
29 Barbosa MMF, Kanno AI, Barazzone GC, Rodriguez D, Pancakova V, Trentini M, Faquim-Mauro EL, Freitas AP, Khouri MI, Lobo-Silva J, Goncalves VM, Schenkman RPF, Tanizaki MM, Boraschi D, Malley R, Farias LP, Leite LCC. Robust Immune Response Induced by Schistosoma mansoni TSP-2 Antigen Coupled to Bacterial Outer Membrane Vesicles. Int J Nanomedicine 2021;16:7153-68. [PMID: 34712047 DOI: 10.2147/IJN.S315786] [Reference Citation Analysis]
30 Nguyen AW, Wagner EK, Posada L, Liu X, Connelly S, Papin JF, Wolf RF, Kaleko M, Maynard JA. Prior exposure to Bordetella species as an exclusion criterion in the baboon model of pertussis. J Vet Med Sci 2017;79:60-4. [PMID: 27666464 DOI: 10.1292/jvms.16-0427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
31 Hasan S, Kulkarni NN, Asbjarnarson A, Linhartova I, Osicka R, Sebo P, Gudmundsson GH. Bordetella pertussis Adenylate Cyclase Toxin Disrupts Functional Integrity of Bronchial Epithelial Layers. Infect Immun 2018;86:e00445-17. [PMID: 29203545 DOI: 10.1128/IAI.00445-17] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
32 Wolf MA, Boehm DT, DeJong MA, Wong TY, Sen-Kilic E, Hall JM, Blackwood CB, Weaver KL, Kelly CO, Kisamore CA, Bitzer GJ, Bevere JR, Barbier M, Damron FH. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice. Infect Immun 2021;89:e00607-20. [PMID: 33318136 DOI: 10.1128/IAI.00607-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
33 Auderset F, Ballester M, Mastelic-Gavillet B, Fontannaz P, Chabaud-Riou M, Reveneau N, Garinot M, Mistretta N, Liu Y, Lambert PH, Ochs M, Siegrist CA. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation. Front Immunol 2019;10:1520. [PMID: 31333656 DOI: 10.3389/fimmu.2019.01520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
34 Cherry JD. The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future. J Pediatric Infect Dis Soc 2019;8:334-41. [PMID: 30793754 DOI: 10.1093/jpids/piz005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
35 Gill C, Rohani P, Thea DM. The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis. F1000Res 2017;6:1568. [PMID: 28928960 DOI: 10.12688/f1000research.11654.1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
36 Cimolai N. Non-primate animal models for pertussis: back to the drawing board? Appl Microbiol Biotechnol 2022. [PMID: 35103810 DOI: 10.1007/s00253-022-11798-1] [Reference Citation Analysis]
37 Salyer ACD, David SA. Transcriptomal signatures of vaccine adjuvants and accessory immunostimulation of sentinel cells by toll-like receptor 2/6 agonists. Hum Vaccin Immunother 2018;14:1686-96. [PMID: 29852079 DOI: 10.1080/21645515.2018.1480284] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
38 Morgan RA, Karl JA, Bussan HE, Heimbruch KE, O'Connor DH, Dudley DM. Restricted MHC class I A locus diversity in olive and hybrid olive/yellow baboons from the Southwest National Primate Research Center. Immunogenetics 2018;70:449-58. [PMID: 29594415 DOI: 10.1007/s00251-018-1057-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]